The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Dik Heg
Showing 1-20 of 23 articles
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement
Okuno T,
Demirel C,
Tomii D,
Heg D,
Häner J,
Siontis G,
Lanz J,
Räber L,
Strotecky S,
Fürholz M,
Praz F,
Windecker S,
Pilgrim T
November 18, 2022 | 10.4244/EIJ-D-22-00342
Five-year outcomes of mild paravalvular regurgitation after transcatheter aortic valve implantation
Okuno T,
Tomii D,
Heg D,
Lanz J,
Praz F,
Stortecky S,
Reineke D,
Windecker S,
Pilgrim T
May 15, 2022 | 10.4244/EIJ-D-21-00784
Prediction of radial crossover in acute coronary syndromes: derivation and validation of the MATRIX score
Gragnano F,
Jolly S,
Mehta SR,
Branca M,
van Klaveren D,
Frigoli E,
Gargiulo G,
Leonardi S,
Vranckx P,
Di Maio D,
Monda E,
Fimiani L,
Fioretti V,
Chianese S,
Andò G,
Esposito G,
Sangiorgi G,
Biondi-Zoccai G,
Heg D,
Calabrò P,
Windecker S,
Romagnoli E,
Valgimigli M
December 17, 2021 | 10.4244/EIJ-D-21-00441
Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition
Gragnano F,
Spirito A,
Corpataux N,
Vaisnora L,
Galea R,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Billinger M,
Hunziker L,
Stortecky S,
Pilgrim T,
Bär S,
Ueki Y,
Capodanno D,
Urban P,
Pocock S,
Mehran R,
Heg D,
Windecker S,
Räber L,
Valgimigli M
December 3, 2021 | 10.4244/EIJ-D-21-00181
Ticagrelor alone or conventional dual antiplatelet therapy in patients with stable or acute coronary syndromes
Franzone A,
McFadden E,
Leonardi S,
Piccolo R,
Vranckx P,
Serruys P,
Hamm C,
Steg PG,
Heg D,
Branca M,
Jüni P,
Windecker S,
Valgimigli M
October 23, 2020 | 10.4244/EIJ-D-20-00145
Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores
Ueki Y,
Bär S,
Losdat S,
Otsuka T,
Zanchin C,
Zanchin T,
Gragnano F,
Gargiulo G,
Siontis G,
Praz F,
Lanz J,
Hunziker L,
Stortecky S,
Pilgrim T,
Heg D,
Valgimigli M,
Windecker S,
Räber L
August 28, 2020 | 10.4244/EIJ-D-20-00052
A comparison of an ultrathin-strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial
Iglesias JF,
Muller O,
Zaugg S,
Roffi M,
Kurz D,
Vuilliomenet A,
Weilenmann D,
Kaiser C,
Tapponnier M,
Heg D,
Valgimigli M,
Eeckhout E,
Jüni P,
Windecker S,
Pilgrim T
August 24, 2018 | 10.4244/EIJ-D-17-00734
Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial
Piccolo R,
Magnani G,
Ariotti S,
Gargiulo G,
Marino M,
Santucci A,
Franzone A,
Tebaldi M,
Heg D,
Windecker S,
Valgimigli M
May 15, 2017 | 10.4244/EIJ-D-16-00497
Comparison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis
Noble S,
Stortecky S,
Heg D,
Tueller D,
Jeger R,
Toggweiler S,
Ferrari E,
Nietlispach F,
Taramasso M,
Maisano F,
Grünenfelder J,
Jüni P,
Huber C,
Carrel T,
Windecker S,
Wenaweser P,
Roffi M
April 7, 2017 | 10.4244/EIJ-D-16-00677
Prognostic impact of invasive haemodynamic measurements in combination with clinical and echocardiographic characteristics on two-year clinical outcomes of patients undergoing transcatheter aortic valve implantation
Franzone A,
O’Sullivan C,
Stortecky S,
Heg D,
Lanz J,
Vollenbroich R,
Praz F,
Piccolo R,
Asami M,
Roost E,
Räber L,
Valgimigli M,
Windecker S,
Pilgrim T
April 7, 2017 | 10.4244/EIJ-D-16-00790
Selective use of contemporary drug-eluting stents in primary angioplasty for ST-elevation myocardial infarction: pooled analysis of COMFORTABLE AMI and EXAMINATION
Baumbach A,
Heg D,
Räber L,
Ostoijc M,
Brugaletta S,
Strange J,
Johnson TW,
Jüni P,
Engstrøm T,
Serruys P,
Sabate M,
Windecker S
January 20, 2017 | 10.4244/EIJ-D-15-00408
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction
Pilgrim T,
Piccolo R,
Heg D,
Roffi M,
Tüller D,
Vuilliomenet A,
Muller O,
Cook S,
Weilenmann D,
Kaiser C,
Jamshidi P,
Khattab A,
Taniwaki M,
Rigamonti F,
Nietlispach F,
Blochlinger S,
Wenaweser P,
Jüni P,
Windecker S
December 9, 2016 | 10.4244/EIJY15M12_09
External validity of a contemporaneous primary percutaneous coronary intervention trial in patients with acute ST-elevation myocardial infarction: insights from a single-centre investigation
Spitzer E,
Hadorn S,
Zanchin T,
Yamaji K,
Moschovitis A,
Pilgrim T,
Stortecky S,
Jüni P,
Heg D,
Windecker S,
Räber L
October 20, 2016 | 10.4244/EIJV12I9A185
Angiographic complexity of coronary artery disease according to SYNTAX score and clinical outcomes after revascularisation with newer-generation drug-eluting stents: a substudy of the BIOSCIENCE trial
Franzone A,
Taniwaki M,
Rigamonti F,
Heg D,
Piccolo R,
Roffi M,
Tüller D,
Muller O,
Vuilliomenet A,
Cook S,
Weilenmann D,
Kaiser C,
Jamshidi P,
Jüni P,
Windecker S,
Pilgrim T
August 5, 2016 | 10.4244/EIJV12I5A99
Effect of resting heart rate on two-year clinical outcomes of high-risk patients with severe symptomatic aortic stenosis undergoing transcatheter aortic valve implantation
O’Sullivan C,
Spitzer E,
Heg D,
Praz F,
Stortecky S,
Huber C,
Carrel T,
Pilgrim T,
Windecker S
July 20, 2016 | 10.4244/EIJV12I4A83
Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials
Taniwaki M,
Stefanini G,
Räber L,
Brugaletta S,
Cequier A,
Heg D,
Iñiguez A,
Kelbæk H,
Serra A,
Ostojic M,
Hernández-Antolín R,
Baumbach A,
Blochlinger S,
Jüni P,
Mainar V,
Sabate M,
Windecker S
August 20, 2015 | 10.4244/EIJY14M07_12
Impact of B-type natriuretic peptide on short-term clinical outcomes following transcatheter aortic valve implantation
O’Sullivan C,
Stortecky S,
Heg D,
Jüni P,
Windecker S,
Wenaweser P
February 20, 2015 | 10.4244/EIJV10I10A200
Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry
Wenaweser P,
Stortecky S,
Heg D,
Tueller D,
Nietlispach F,
Falk V,
Pedrazzini G,
Jeger R,
Reuthebuch O,
Carrel T,
Räber L,
Amann F,
Ferrari E,
Toggweiler S,
Noble S,
Roffi M,
Gruenenfelder J,
Jüni P,
Windecker S,
Huber C
December 22, 2014 | 10.4244/EIJV10I8A166
Extent and distribution of calcification of both the aortic annulus and the left ventricular outflow tract predict aortic regurgitation after transcatheter aortic valve replacement
Buellesfeld L,
Stortecky S,
Heg D,
Gloekler S,
Meier B,
Wenaweser P,
Windecker S
October 20, 2014 | 10.4244/EIJV10I6A126
Accuracy and reproducibility of aortic annulus sizing using a dedicated three-dimensional computed tomography reconstruction tool in patients evaluated for transcatheter aortic valve replacement
Stortecky S,
Heg D,
Gloekler S,
Wenaweser P,
Windecker S,
Buellesfeld L
July 21, 2014 | 10.4244/EIJV10I3A59
1
2
Latest news
AHEAD OF PRINT
Ostial RCA ISR: mechanisms and treatment outcomes
FREE ARTICLE - Kei Yamamoto et al
June 7, 2023
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
NEW ISSUE
Expert Review on Calcified CTOs; Calcified Nodules Revascularisation Debate; CTO PCI; Stent Failure and Calcified Nodules and more...
June 5, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke